tiprankstipranks
Trending News
More News >
Pharvaris (PHVS)
NASDAQ:PHVS

Compare Pharvaris (PHVS) vs. Competitors

Compare
156 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Pharvaris
$26.00
$1.64B
60.19%
8 Buy
1 Hold
0 Sell
Strong Buy
BioCryst
$6.78
$1.43B
-6.22%
8 Buy
2 Hold
0 Sell
Strong Buy
Celldex
$26.34
$1.75B
-7.79
14.82%
9 Buy
0 Hold
1 Sell
Strong Buy
Viridian Therapeutics
$31.99
$3.22B
-9.56
100.36%
17 Buy
0 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$28.17
$2.98B
-17.86
2.36%
8 Buy
1 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$11.70
$1.70B
-67.11%
8 Buy
6 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHVS
Pharvaris
25.63
8.98
53.93%
BCRX
BioCryst
6.78
-0.45
-6.22%
CLDX
Celldex
26.34
3.72
16.45%
VRDN
Viridian Therapeutics
33.78
16.39
94.25%
EWTX
Edgewise Therapeutics
28.17
-0.03
-0.11%
BHVN
Biohaven Ltd.
11.70
-24.49
-67.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts